Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine.
Proteomic analysis of extracellular vesicles (EVs) from biological fluid is a powerful approach to discover potential biomarkers for human diseases including cancers, as EV secreted to biological fluids are originated from the affected tissue. In order to investigate significant molecules related to the pathogenesis of bladder cancer, EVs were isolated from patient urine which was analyzed by mass spectrometry based proteomics. Comparison of the EV proteome to the whole urine proteome demonstrated an increased number of protein identification in EV. Comparative MS analyses of urinary EV from control subjects and bladder cancer patients identified a total of 1,222 proteins. Statistical analyses provided 56 proteins significantly increased in bladder cancer urine, including proteins for which expression levels varied by cancer stage (P-value < 0.05). While urine represents a valuable, noninvasive specimen for biomarker discovery in urologic cancers, there is a high degree of intra- and inter-individual variability in urine samples. The enrichment of urinary EV demonstrated its capability and applicability of providing a focused identification of biologically relevant proteins in urological diseases.
['Lee|Jingyun|J|', 'McKinney|Kimberly Q|KQ|', 'Pavlopoulos|Antonis J|AJ|', 'Niu|Meng|M|', 'Kang|Jung Won|JW|', 'Oh|Jae Won|JW|', 'Kim|Kwang Pyo|KP|', 'Hwang|Sunil|S|']
D015415:Biomarkers D000067128:Extracellular Vesicles D005260:Female D006801:Humans D008297:Male D020543:Proteome D040901:Proteomics D001749:Urinary Bladder Neoplasms
bladder cancer biomarker discovery para-clinical classification ultracentrifugation urinary extracellular vesicles